首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Digestive And Liver Disease

Digestive And Liver Disease杂志,由Elsevier出版,于2000年创刊,Monthly,出版语言English,ISSN:1590-8658,E-ISSN:1878-3562。

投稿咨询
Digestive And Liver Disease
Digestive And Liver Disease
Digestive And Liver Disease
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
3区
影响因子
4.9
CiteScore
6.4
期刊收录
SCI、SCIE

Digestive And Liver Disease(中文译名:《消化和肝病》),ISSN:1590-8658,EISSN:1878-3562,是Elsevier出版的国际性学术期刊,创刊于2000年,以Monthly形式稳定发行,2026年总发文量约260篇。该刊采用非OA开放访问,学科归属为医学 - 胃肠肝病学。该刊是医学、胃肠肝病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.9,2025年期刊CiteScore为6.4,2025年期刊自引率约6.1%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Digestive And Liver Disease长期聚焦医学、胃肠肝病学及相关产业的技术应用前沿,平均审稿周期一般,3-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、胃肠肝病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,ItalyUSA、France、CHINA MAINLAND、England、Spain、GERMANY (FED REP GER)等为核心发文国家与地区;UNIVERSITY OF PADUAUNIVERSITY OF BOLOGNA、UNIVERSITY OF MILAN、CATHOLIC UNIVERSITY OF THE SACRED HEART、SAPIENZA UNIVERSITY ROME、IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO、IRCCS HUMANITAS RESEARCH HOSPITAL等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 34 / 153

78.1

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 32 / 153

79.41

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q2 41 / 148

72.6

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 36 / 148

76.01


中国学者近期发文

1
Reconsidering the clinical implications of oral butyrate supplementation in inflammatory bowel diseas

Author:Zhang, Yanqin; Dai, Liuhong; Ma, Teng

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 563-564. DOI: 10.1016/j.dld.2026.01.001

2
Rapidly growing esophageal pyogenic granuloma: A case report and review of the literatur

Author:Zhang, Xiaoxia; Li, Jianjun; Diao, Xinwei; Huang, Ying; Qiao, Qiujian; Bai, Jianying; Peng, Xue

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 473-478. DOI: 10.1016/j.dld.2026.01.209

3
The Duration-Driven exit strategy: Is time the ultimate predictor of sustained remission after biologic cessation

Author:Zhang, Lidan; Shang, Kun; Zhang, Xin

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 567-568. DOI: 10.1016/j.dld.2026.01.212

4
Deep learning for histopathological diagnosis of esophageal squamous cell carcinoma in biopsies: A multicenter analysi

Author:Xu, Guixuan; Zhao, Jianmin; Zhang, Haijun; Li, Mo; Wang, Kaige; Zhang, Ying; Zhao, Lingyu; Sun, Shuyan; Liu, Chunxia; Zhao, Jin; Zhang, Wenjie; Zhang, Xiaojun; Wang, Shuhao; Yang, Lan; Cui, Xiaobin; Zhong, Dingrong; Li, Feng

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 549-555. DOI: 10.1016/j.dld.2026.01.230

5
Red Flags Index and faecal calprotectin in Korea: implications for primary-care triage in Crohn's diseas

Author:Xie, Haiyang; Liang, Daoye; Lin, Hua; He, Xinxin

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 575-576. DOI:

6
Author's reply: Clinical prediction models in minimal hepatic encephalopathy: How far can they go

Author:Xie, Cong; Wang, Jingyu; Meng, Yushan; Huang, Yining; Zhang, Hang; Cao, Bin

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 571-572. DOI: 10.1016/j.dld.2026.02.006

7
Clinical readiness of AI in early gastric cancer: A call for real-world validation and equitable implementatio

Author:Lu, Yawen; Hu, Yang; He, Yuqi

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 573-574. DOI: 10.1016/j.dld.2025.11.018

8
Toward clinical implementation of interpretable machine learning for early risk stratification in acute pancreatiti

Author:Huang, Yicheng; Yu, Zichen

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 577-578. DOI: 10.1016/j.dld.2026.01.002

9
Association between serum HBV DNA levels and liver fibrosis in chronic hepatitis

Author:Fan, Tao; Wang, Jian; Zhu, Li; Xiong, Ye; Zhang, Shaoqiu; Liu, Jiacheng; Jiang, Chao; Yin, Shengxia; Tong, Xin; Wang, Guiyang; Jia, Bei; Xia, Juan; Yan, Xiaomin; Yao, Renling; Chen, Yuxin; Shi, Yu; Liu, Xingxiang; Qiu, Yuanwang; Geng, Taoran; Zhang, Qun; Zhu, Chuanwu; Wu, Chao; Huang, Rui

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 503-510. DOI: 10.1016/j.dld.2026.01.205

10
Metabolic liver imaging: What you need to kno

Author:Asmundo, Luigi; Mojtahed, Amirkasra; Prakash, Samay; Pierce, Theodore T.; Wei, Jingwei; Vanzulli, Angelo

Journal: DIGESTIVE AND LIVER DISEASE. 2026; Vol. 58, Issue 4, pp. 433-443. DOI: 10.1016/j.dld.2026.02.010


在线咨询

Digestive And Liver Disease

国际简称:DIGEST LIVER DIS参考译名:消化和肝病

年发文量:260 CiteScore:6.4 是否预警:否 Gold OA文章占比:23.22% 研究类文章占比:92.31%

杂志社联系方式:ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Digestive And Liver Disease